^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG CLASS:

    PIM inhibitor

    Related drugs:
    Apply
    SEL24/MEN1703 in Patients With Acute Myeloid Leukemia (DIAMOND-01) (NCT03008187)
    Phase 1/2
    Menarini Group
    Completed
    Last update posted :
    05/09/2024
    Initiation :
    03/10/2017
    Primary completion :
    04/13/2023
    Completion :
    04/13/2023
    IDH1 • IDH2
    |
    IDH2 mutation
    |
    dapolsertib (MEN1703)